| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Revenue | $862.4M | +41.7% |
| Cost of Revenue | $232.2M | +44.2% |
| Gross Profit | $630.2M | +40.8% |
| R&D Expense | $273.8M | +37.4% |
| SG&A Expense | $123.4M | +18.9% |
| Operating Income | -$173.7M | -34.1% |
| Interest Expense | $20.7M | — |
| Pre-tax Income | -$197.8M | -62.5% |
| Income Tax | $6.1M |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $860.9M | +114.8% |
| Accounts Receivable | $215.2M | +34.2% |
| Current Assets | $1.16B | +82.6% |
| Total Assets | $1.64B | +68.8% |
| Current Liabilities | $593.3M | +31.8% |
| Long-term Debt | $566.5M | — |
| Total Liabilities | $1.23B | +135.0% |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.7M | -74.8% |
| Capital Expenditures | $2.5M | -36.5% |
| Investing Cash Flow | -$127.3M | -8284.1% |
| Financing Cash Flow | $602.1M | +679.4% |
| Free Cash Flow | $3.2M | -82.9% |
| -21.5% |
| Net Income | -$203.8M | -57.5% |
| EPS (Basic) | -$2.20 | -48.6% |
| EPS (Diluted) | -$2.20 | -48.6% |
| Stockholders' Equity |
| $415.4M |
| -7.9% |